» Articles » PMID: 24898545

Prevalence of Chronic Thromboembolic Pulmonary Hypertension After Acute Pulmonary Embolism. Prevalence of CTEPH After Pulmonary Embolism

Overview
Journal Thromb Haemost
Publisher Thieme
Date 2014 Jun 6
PMID 24898545
Citations 98
Authors
Affiliations
Soon will be listed here.
Abstract

Chronic thromboembolic pulmonary hypertension (CTEPH) has been estimated to occur in 0.1-0.5% of patients who survive a pulmonary embolism (PE), but more recent prospective studies suggest that its incidence may be much higher. The absence of initial haemodynamic evaluation at the time of PE should explain this discrepancy. We performed a prospective multicentre study including patients with PE in order to assess the prevalence and to describe risk factors of CTEPH. Follow-up every year included an evaluation of dyspnea and echocardiography using a predefined algorithm. In case of suspected CTEPH, the diagnosis was confirmed using right heart catheterisation (RHC). Signs of CTEPH were searched on the multidetector computed tomography (CT) and echocardiography performed at the time of PE. Of the 146 patients analysed, eight patients (5.4%) had suspected CTEPH during a median follow-up of 26 months. CTEPH was confirmed using RHC in seven cases (4.8%; 95%CI, 2.3 - 9.6) and ruled-out in one. Patients with CTEPH were older, had more frequently previous venous thromboembolic events and more proximal PE than those without CTEPH. At the time of PE diagnosis, patients with CTEPH had a higher systolic pulmonary artery pressure and at least two signs of CTEPH on the initial CT. After acute PE, the prevalence of CTEPH appears high. However, initial echocardiography and CT data at the time of the index PE suggest that a majority of patients with CTEPH had previously unknown pulmonary hypertension, indicating that a first clinical presentation of CTEPH may mimic acute PE.

Citing Articles

[Diagnosis and treatment of acute pulmonary embolism].

Hecker M, Bayer M, Krombach G, Sommer N Med Klin Intensivmed Notfmed. 2025; .

PMID: 40047895 DOI: 10.1007/s00063-025-01249-w.


Meta-Analysis of Real-World Clinical Practice to Assess the Effectiveness of Riociguat in Treating Chronic Thromboembolic Pulmonary Hypertension.

Pamukcu E, Kaya M J Clin Hypertens (Greenwich). 2025; 27(2):e70015.

PMID: 39957705 PMC: 11831188. DOI: 10.1111/jch.70015.


Advanced Management of Patients Undergoing Transcatheter Treatment for Pulmonary Embolism: Evidence-Based Strategies for Optimized Patient Care.

Costa F, Jurado-Roman A, Carciotto G, Becerra-Munoz V, Marquez D, Gotzinger F J Clin Med. 2025; 13(24.

PMID: 39768703 PMC: 11727837. DOI: 10.3390/jcm13247780.


From Pulmonary Embolism to Chronic Thromboembolic Pulmonary Hypertension: A Pathophysiological Approach.

Shahidi P, Mentzel L, Blazek S, Sulimov D, Thiele H, Fengler K Rev Cardiovasc Med. 2024; 25(11):402.

PMID: 39618872 PMC: 11607516. DOI: 10.31083/j.rcm2511402.


Chronic thromboembolic pulmonary hypertension: the diagnostic assessment.

Simeone B, Maggio E, Schirone L, Rocco E, Sarto G, Spadafora L Front Cardiovasc Med. 2024; 11:1439402.

PMID: 39309600 PMC: 11412851. DOI: 10.3389/fcvm.2024.1439402.